GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Cyclically Adjusted FCF per Share

Hwail Pharm Co (XKRX:061250) Cyclically Adjusted FCF per Share : ₩54.07 (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Hwail Pharm Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Hwail Pharm Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ₩-10.191. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩54.07 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Hwail Pharm Co's average Cyclically Adjusted FCF Growth Rate was 56.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 78.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 37.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Hwail Pharm Co was 92.00% per year. The lowest was 9.30% per year. And the median was 78.40% per year.

As of today (2024-05-26), Hwail Pharm Co's current stock price is ₩1557.00. Hwail Pharm Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ₩54.07. Hwail Pharm Co's Cyclically Adjusted Price-to-FCF of today is 28.80.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Hwail Pharm Co was 1467.05. The lowest was 28.79. And the median was 101.04.


Hwail Pharm Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Hwail Pharm Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hwail Pharm Co Cyclically Adjusted FCF per Share Chart

Hwail Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.87 8.82 29.84 34.45 50.10

Hwail Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.66 48.58 45.66 50.10 54.07

Competitive Comparison of Hwail Pharm Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Hwail Pharm Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hwail Pharm Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hwail Pharm Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Hwail Pharm Co's Cyclically Adjusted Price-to-FCF falls into.



Hwail Pharm Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hwail Pharm Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-10.191/118.8477*118.8477
=-10.191

Current CPI (Mar. 2024) = 118.8477.

Hwail Pharm Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -11.715 99.353 -14.014
201409 89.351 99.608 106.610
201412 -143.508 99.098 -172.108
201503 -23.453 99.720 -27.952
201506 6.222 100.050 7.391
201509 -213.597 100.110 -253.576
201512 18.711 100.220 22.189
201603 -3.118 100.560 -3.685
201606 117.457 100.790 138.501
201609 89.562 101.460 104.911
201612 22.106 101.560 25.869
201703 36.745 102.850 42.460
201706 -7.753 102.610 -8.980
201709 3.419 103.490 3.926
201712 158.174 102.990 182.529
201803 50.691 104.100 57.872
201806 19.521 104.130 22.280
201809 52.975 105.650 59.593
201812 15.665 104.350 17.841
201903 -66.050 104.490 -75.126
201906 41.732 104.880 47.290
201909 97.858 105.200 110.553
201912 -8.096 105.120 -9.153
202003 -54.605 105.540 -61.490
202006 -34.185 104.870 -38.741
202009 0.441 106.200 0.494
202012 50.229 105.765 56.442
202103 78.097 107.357 86.456
202106 34.972 107.579 38.635
202109 137.369 108.759 150.111
202112 25.210 109.676 27.318
202203 46.136 111.806 49.042
202206 18.962 114.083 19.754
202209 -87.866 114.831 -90.939
202212 -147.010 115.200 -151.665
202303 -59.942 116.550 -61.124
202306 -94.839 117.140 -96.222
202309 82.001 119.111 81.820
202312 155.809 118.848 155.809
202403 -10.191 118.848 -10.191

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Hwail Pharm Co  (XKRX:061250) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Hwail Pharm Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=1557.00/54.07
=28.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Hwail Pharm Co was 1467.05. The lowest was 28.79. And the median was 101.04.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Hwail Pharm Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Hwail Pharm Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hwail Pharm Co (XKRX:061250) Business Description

Traded in Other Exchanges
N/A
Address
904-7, Sangsin-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-746
Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.

Hwail Pharm Co (XKRX:061250) Headlines

No Headlines